# Pharma Nobis LLC - Inspection Records

Source: https://www.keypedia.com/companies/pharma-nobis-llc/65e636d3-cd04-456d-b82a-a681bb7bdb9e

> Inspection records and compliance data for Pharma Nobis LLC in Texarkana, Texas. Access full analysis and detailed observations.

---

## Details

- Name: Pharma Nobis LLC
- FEI Number: 1611206
- City: Texarkana
- State: Texas
- Country Name: United States
- Address Line 1: 7400 Alumax Rd
- Zip Code: 75501

## Related Documents

- [483 - Pharma Nobis LLC - 2025-07-25](https://www.keypedia.com/records/483/pharma-nobis-llc/416a69dd-78dd-4267-8432-cf07bcaf759d) — source: FDA, date: July 25, 2025
- [FDA Inspection 1254643 - Pharma Nobis LLC - 2025-07-25](https://www.keypedia.com/records/fda_inspections/pharma-nobis-llc/b6cbf362-5c94-4e90-b962-74f0028b790b) — source: FDA, date: July 25, 2025
- [FDA Inspection 1254643 - Pharma Nobis LLC - 2025-07-25](https://www.keypedia.com/records/fda_inspections/pharma-nobis-llc/b276634f-255c-4821-9f0d-618d4945fc10) — classification: Voluntary Action Indicated (VAI), source: FDA, date: July 25, 2025
- [483 - Pharma Nobis LLC - 2020-03-13](https://www.keypedia.com/records/483/pharma-nobis-llc/811120a6-d13f-42af-9a81-d010417518de) — source: FDA, date: March 13, 2020
- [FDA Inspection 1121963 - Pharma Nobis LLC - 2020-03-13](https://www.keypedia.com/records/fda_inspections/pharma-nobis-llc/55bf03bc-0b85-4b94-add8-623ddd2f2893) — classification: Official Action Indicated (OAI), source: FDA, date: March 13, 2020
- [FDA Inspection 1067901 - Pharma Nobis LLC - 2018-08-07](https://www.keypedia.com/records/fda_inspections/pharma-nobis-llc/3c8e9b60-2e67-4fec-8ff9-bb8a0661181d) — classification: No Action Indicated (NAI), source: FDA, date: August 7, 2018
- [FDA Inspection 1061996 - Pharma Nobis LLC - 2018-03-26](https://www.keypedia.com/records/fda_inspections/pharma-nobis-llc/3e37c18f-ef4c-43fa-9bef-ec8c75a8e794) — classification: No Action Indicated (NAI), source: FDA, date: March 26, 2018
- [483 - Pharma Nobis LLC - 2015-07-01](https://www.keypedia.com/records/483/pharma-nobis-llc/972e0fc9-24aa-4684-8eb6-129b0a4e644e) — source: FDA, date: July 1, 2015
- [FDA Inspection 934827 - Pharma Nobis LLC - 2015-07-01](https://www.keypedia.com/records/fda_inspections/pharma-nobis-llc/8e2ccf9e-74f0-487c-b98a-8a70ab8fd9a6) — classification: Official Action Indicated (OAI), source: FDA, date: July 1, 2015
- [FDA Inspection 934827 - Pharma Nobis LLC - 2015-07-01](https://www.keypedia.com/records/fda_inspections/pharma-nobis-llc/de7ee8d7-efb2-4122-a280-7af393a6fa49) — classification: No Action Indicated (NAI), source: FDA, date: July 1, 2015
- [FDA Inspection 841659 - Pharma Nobis LLC - 2013-07-24](https://www.keypedia.com/records/fda_inspections/pharma-nobis-llc/107651c1-9d82-486a-a4b8-1d54f2d6387f) — classification: Voluntary Action Indicated (VAI), source: FDA, date: July 24, 2013
- [FDA Inspection 841659 - Pharma Nobis LLC - 2013-07-24](https://www.keypedia.com/records/fda_inspections/pharma-nobis-llc/9cd76630-93e1-4e17-b9a2-c711d016bfb4) — classification: Voluntary Action Indicated (VAI), source: FDA, date: July 24, 2013
- [FDA Inspection 768845 - Pharma Nobis LLC - 2012-03-16](https://www.keypedia.com/records/fda_inspections/pharma-nobis-llc/8fc45941-a625-4ed9-81f7-20e6753dcb7d) — classification: No Action Indicated (NAI), source: FDA, date: March 16, 2012

## Related Companies

- [Sandoz GmbH](https://www.keypedia.com/companies/sandoz-gmbh/06a6ffcd-311c-4e6b-8087-573378a1ad87)
- [Bakelite Chemicals LLC](https://www.keypedia.com/companies/bakelite-chemicals-llc/77828887-3e5a-4cff-bcca-3423659055d3)
- [Cosco International, Inc.](https://www.keypedia.com/companies/cosco-international-inc/1d902093-955a-4d4e-b6ac-e4deff1773a6)
- [Halocarbon Life Sciences, LLC](https://www.keypedia.com/companies/halocarbon-life-sciences-llc/22b56b6b-8819-4f99-a714-1b385e813064)
- [Sandoz GmbH](https://www.keypedia.com/companies/sandoz-gmbh/02a3eaeb-a765-43ae-873b-93d1d1523696)
- [Baxter Healthcare Corporation](https://www.keypedia.com/companies/baxter-healthcare-corporation/511e2b34-f9c9-4059-b74d-d1cd59ed6678)
- [OXYGEN DEVELOPMENT, L.L.C.](https://www.keypedia.com/companies/oxygen-development-llc/024c27c1-6cfa-4c7b-9daf-9005cbf515b7)
- [Kindeva Drug Delivery Limited](https://www.keypedia.com/companies/kindeva-drug-delivery-limited/901e9a7f-5182-43e1-9980-391fca7364b7)
- [Ecolab, Inc.](https://www.keypedia.com/companies/ecolab-inc/b1f974bf-f8ce-4704-bbe7-2b1cc3d35c03)
- [Aphena Pharma Solutions-Maryland LLC](https://www.keypedia.com/companies/aphena-pharma-solutions-maryland-llc/97893fd6-3370-41f2-95ce-17928ab057e2)

## Related Officers

- [Yumi Hiramine](https://www.keypedia.com/people/yumi-hiramine/26c5059f-8f61-42cf-ae79-65a7b942d2c7)
- [Carlos Chavez](https://www.keypedia.com/people/carlos-chavez/63494a03-ee07-4a25-9298-75259b621c57)
- [Investigator](https://www.keypedia.com/people/shanna-n-purdy/7a677cf5-484f-4e9a-91b1-27398411ff32)
- [Michelle A. Krayer](https://www.keypedia.com/people/michelle-a-krayer/c68b88a6-d3d3-4407-867b-81b92b7ce977)
- [investigator](https://www.keypedia.com/people/timothy-h-vo/08da7ca5-7f58-42bf-8046-e3a1bf879b48)